A major new cardiovascular study on glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is sharpening an already fraught question for Canadian employers: How far should group benefits go in funding expensive diabetes and obesity drugs that may need to be taken for years
Wegovy and Zepbound are registered trademarks of their respective manufacturers.
Con un farmaco come Rybelsus, per, la prudenza viene prima di tutto
Managing Constipation and Digestion with Magnesium Support Constipation ranks among the most common side effects of GLP-1 therapy, occurring because semaglutide slows gastric emptying and reduces overall food volume
Eating smaller, balanced meals, staying hydrated, and avoiding very rich foods often help
In addition, it may also have a beneficial effect on cardiovascular health, although this area still needs further research